CPRX P/B: current value, 10-year range and year-by-year history
Cash & Leverage
CPRX's p/b is right around its 10-year median of 4.0.
P/B History
CPRX P/B by year
Yearly range of CPRX’s p/b from 2016 to 2026. Over the full period it ranged from 1.9 to 12.4, averaging 4.5.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 3.0 | 3.5 | 3.9 | 3.9 |
| 2025 | 2.7 | 3.4 | 4.5 | 3.1 |
| 2024 | 3.1 | 3.9 | 5.0 | 3.6 |
| 2023 | 3.5 | 4.8 | 8.0 | 5.1 |
| 2022 | 2.8 | 4.8 | 8.1 | 7.7 |
| 2021 | 2.2 | 3.1 | 4.0 | 3.6 |
| 2020 | 2.0 | 3.9 | 6.3 | 2.1 |
| 2019 | 4.3 | 7.5 | 12.4 | 4.6 |
| 2018 | 2.7 | 4.2 | 5.8 | 3.9 |
| 2017 | 2.3 | 5.8 | 11.8 | 10.4 |
| 2016 | 1.9 | 2.1 | 2.4 | 2.0 |
Get notified when CPRX P/B crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays relative to the company's accounting net worth (assets minus liabilities). P/B < 1 means the market values the company below what the books say it owns.
Price / Book Value Per ShareMost useful for asset-heavy businesses: banks, insurers, REITs. A P/B near its historical low suggests the market is paying unusually little for the net assets.
- Goodwill and intangibles from acquisitions can inflate book value significantly — some analysts prefer tangible book value.
- Low P/B in technology or software companies is usually irrelevant: their value is in IP and people, not balance sheet assets.
Is CPRX P/B High or Low Right Now?
Catalyst Pharmaceuticals, Inc.'s P/B is currently 3.9, which is around average relative to its 10-year historical range. The 10-year median P/B for CPRX is approximately 4.0. See all CPRX valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.